Puwainaphycin A (9CI)(142998-30-9)
- Name: Puwainaphycin A (9CI)
- Synonyms:PuwainaphycinC, 9-[(2R,3R,4S)-2-hydroxy-4-methyl-14-oxo-3-aminooctadecanoic acid]-;1H-Pyrrolo[2,1-c][1,4,7,10,13,16,19,22,25,28]decaazacyclohentriacontine, cyclicpeptide deriv.;Cyclo[(E)-2,3-didehydro-2-aminobutanoyl-L-threonyl-L-threonyl-L-glutaminylglycyl-O-methyl-L-threonyl-N2-methyl-L-asparaginyl-L-prolyl-(2R,3R,4S)-2-hydroxy-4-methyl-14-oxo-3-aminooctadecanoyl-L-valyl]
- Molecular Formula:C58H98 N12 O17
- Molecular Weight:1235.49
- CAS Registry Number:142998-30-9
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 209851-35-4/2H-Pyran-4-acetic acid,2-[[6-O-[(2E)-3-(3,4-dihydroxyphenyl)- 1-oxo-2-propenyl]-â-Dglucopyranosyl] oxy]-3,4-dihydro-3-(2- hydroxyethylidene)-5-(methoxycarbonyl)-,2- (3,4-dihydroxyphenyl)ethyl ester,(2S,3E,4S)-
- 107668-79-1/Bulleyaconitine A
- 142979-92-8/5,5-bis{[(4-aminobenzyl)sulfanyl]methyl}imidazolidine-2,4-dione
- 33913-64-3/(3beta,5alpha,8xi,9xi,14xi)-3-(1-methylpyrrolidinium-1-yl)androstan-17-one iodide
- 144732-34-3/3,7-diamino-2-hydroxyheptanoyl-leucyl-proline
- 72429-69-7/IV(4)-galactosyl-N-acetylganglioside GD1a
- 62899-01-8/N(1),N(3)-diallyl-6-methyluracil
- 98532-64-0/1-{[(2R,4R)-2-(1-benzofuran-2-yl)-4-(methoxymethyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2,4-triazole
- 106710-53-6/N-(3,5-dimethyl-1,1-dioxido-2H-1,2-thiazin-2-yl)-4-nitrobenzamide
- 73728-55-9/9H-Fluorene-2-methanol
- 6018-54-8/DL-2,3-DIAMINOPROPANOICACID
- 59337-01-8/N-{[2-(1H-benzimidazol-1-yl)ethyl]carbamoyl}butanamide
- 84176-71-6/ethyl 4-[2-(diethylamino)ethoxy]-4-phenylpiperidine-1-carboxylate
- 84434-45-7/2-methyl-6-[(2-methylphenyl)azo]benzene-1,3-diamine
- 91860-73-0/dioleoylphosphatidylthioglycerol
- 91001-95-5/Fatty acids, C13-17 and C15-21-unsatd., tetraesters with pentaerythritol
- 102233-21-6/1-Piperazineethanol,4,4'-(1,6-hexanediyl)bis[a-(chloromethyl)-, tetrahydrochloride (9CI)
- 68201-80-9/Citric acid, ammonium iron(3+) manganese(2+) zinc salt
- 156980-51-7/b-D-Glucopyranosiduronic acid, (3b,4b,20a)-20-carboxy-23-hydroxy-22-oxo-30-norolean-12-en-3-yl 2-O-b-D-glucopyranuronosyl-
- 142998-30-9/Puwainaphycin A (9CI)
- 129420-93-5/edil
- 87564-37-2/1,1',1'',1'''-[(8,18-dichloro-5,15-diethyl-5,15-dihydrodiindolo[3,2-b:3',2'-m]triphenodioxazinetetrayl)tetrakis[methyleneimino(2-oxoethylene)]]tetrapyridinium tetrachloride
- 72986-51-7/1,3-Benzenedicarbonyl dichloride, polymer with 1,4-benzenedicarbonyl dichloride and 2-chloro-1,4-benzenediamine dihydrochloride
- 81831-80-3/Trioxacarcin
- 10125-85-6/1,1-dimethyl-4-phenylpiperidinium iodide
- 93092-29-6/Myrtiaphenone A
- 132052-17-6/CobC protein
- 42351-76-8/3-(3-chlorophenyl)imidazolidine-2,4-dione
- 38963-55-2/(Z)-2-Methyl-2-butenoic acid [(3aS)-2,3,3a,4,5,5a,6,9,9aβ,9bα-decahydro-5aα-methyl-3,9-bis(methylene)-2-oxonaphtho[1,2-b]furan-6β-yl] ester
- 112997-57-6/piperidinium 4-oxo-4-(phenylamino)butanoate